BACKGROUND: We conducted a study to investigate the impact of hospitalization for hematopoietic stem cell transplantation (HCT) on the quality of life (QOL) and mood of patients and family caregivers (FC). METHODS: We conducted a longitudinal study of patients who were hospitalized for HCT and their FC. We assessed QOL (using the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation) and mood (using the Hospital Anxiety and Depression Scale) at baseline (6 days before HCT), day +1, and day +8 of HCT. We administered the Medical Outcomes Study Health Survey Short Form-36 to examine FC QOL (Physical Component Scale and Mental Component Scale). To identify predictors of changes in QOL, we used multivariable linear mixed models. RESULTS: We enrolled 97% of eligible patients undergoing autologous (30 patients), myeloablative (30 patients), or reduced intensity (30 patients) allogeneic HCT. Patients' QOL markedly declined (mean Functional Assessment of Cancer Therapy-Bone Marrow Transplantation score, 109.6 to 96.0; P<.0001) throughout hospitalization. The percentage of patients with depression (Hospital Anxiety and Depression Scale-Depression score of >7) more than doubled from baseline to day +8 (15.6% to 37.8%; P<.0001), whereas the percentage of patients with anxiety remained stable (22.2%; P = .8). These results remained consistent when data were stratified by HCT type. Baseline depression (β, -2.24; F, 42.2 [P<.0001]) and anxiety (β, -0.63; F, 4.4 [P =.03]) were found to independently predict worse QOL throughout hospitalization. FC QOL declined during the patient's hospitalization (physical component scale: 83.1 to 79.6 [P =.03] and mental component scale: 71.6 to 67.4 [P =.04]). CONCLUSIONS: Patients undergoing HCT reported a steep deterioration in QOL and substantially worsening depression during hospitalization. Baseline anxiety and depression predicted worse QOL during hospitalization, underscoring the importance of assessing pre-HCT psychiatric morbidity.
BACKGROUND: We conducted a study to investigate the impact of hospitalization for hematopoietic stem cell transplantation (HCT) on the quality of life (QOL) and mood of patients and family caregivers (FC). METHODS: We conducted a longitudinal study of patients who were hospitalized for HCT and their FC. We assessed QOL (using the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation) and mood (using the Hospital Anxiety and Depression Scale) at baseline (6 days before HCT), day +1, and day +8 of HCT. We administered the Medical Outcomes Study Health Survey Short Form-36 to examine FC QOL (Physical Component Scale and Mental Component Scale). To identify predictors of changes in QOL, we used multivariable linear mixed models. RESULTS: We enrolled 97% of eligible patients undergoing autologous (30 patients), myeloablative (30 patients), or reduced intensity (30 patients) allogeneic HCT. Patients' QOL markedly declined (mean Functional Assessment of Cancer Therapy-Bone Marrow Transplantation score, 109.6 to 96.0; P<.0001) throughout hospitalization. The percentage of patients with depression (Hospital Anxiety and Depression Scale-Depression score of >7) more than doubled from baseline to day +8 (15.6% to 37.8%; P<.0001), whereas the percentage of patients with anxiety remained stable (22.2%; P = .8). These results remained consistent when data were stratified by HCT type. Baseline depression (β, -2.24; F, 42.2 [P<.0001]) and anxiety (β, -0.63; F, 4.4 [P =.03]) were found to independently predict worse QOL throughout hospitalization. FC QOL declined during the patient's hospitalization (physical component scale: 83.1 to 79.6 [P =.03] and mental component scale: 71.6 to 67.4 [P =.04]). CONCLUSIONS:Patients undergoing HCT reported a steep deterioration in QOL and substantially worsening depression during hospitalization. Baseline anxiety and depression predicted worse QOL during hospitalization, underscoring the importance of assessing pre-HCT psychiatric morbidity.
Authors: Stephanie J Lee; Steven Joffe; Haesook T Kim; Gerard Socie; Andrew L Gilman; John R Wingard; Mary M Horowitz; David Cella; Karen L Syrjala Journal: Blood Date: 2004-06-15 Impact factor: 22.113
Authors: Catherine E Mosher; William H Redd; Christine M Rini; Jack E Burkhalter; Katherine N DuHamel Journal: Psychooncology Date: 2009-02 Impact factor: 3.894
Authors: A M J Braamse; M M J G Gerrits; B van Meijel; O Visser; P van Oppen; A D Boenink; P Cuijpers; P C Huijgens; A T F Beekman; J Dekker Journal: Bone Marrow Transplant Date: 2011-07-04 Impact factor: 5.483
Authors: Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer Journal: Blood Date: 2005-06-30 Impact factor: 22.113
Authors: Marlene Z Cohen; Cathy L Rozmus; Tito R Mendoza; Nikhil S Padhye; Joyce Neumann; Ibrahima Gning; Ana Aleman; Sergio Giralt; Charles S Cleeland Journal: J Pain Symptom Manage Date: 2012-06-13 Impact factor: 3.612
Authors: Maria-Jose Santana; Heather-Jane Au; Melina Dharma-Wardene; Joanne D Hewitt; David Dupere; John Hanson; Sunita Ghosh; David Feeny Journal: Int J Technol Assess Health Care Date: 2009-01 Impact factor: 2.188
Authors: Jessica L Markham; Matthew Hall; Mary Ann Queen; Paul L Aronson; Sowdhamini S Wallace; Dana M Foradori; Gabrielle Hester; Jennifer Nead; Michelle A Lopez; Andrea T Cruz; Russell J McCulloh Journal: Hosp Pediatr Date: 2019-01
Authors: Anna Barata; Brian D Gonzalez; Steven K Sutton; Brent J Small; Paul B Jacobsen; Teresa Field; Hugo Fernandez; Heather Sl Jim Journal: J Health Psychol Date: 2016-04-22
Authors: Harriet L Mather; Heather Coats; Kristen Desanto; J Nicholas Dionne-Odom; Cardinale B Smith; Laura P Gelfman Journal: J Palliat Med Date: 2019-04 Impact factor: 2.947
Authors: Alex J Fauer; Flora Hoodin; Leah Lalonde; Josh Errickson; Lyndsey Runaas; Tracey Churay; Sajjad Seyedsalehi; Casiana Warfield; Grant Chappell; Kristina Brookshire; Dima Chaar; Ji Youn Shin; Michelle Byrd; John Magenau; David A Hanauer; Sung Won Choi Journal: Support Care Cancer Date: 2018-09-20 Impact factor: 3.603
Authors: Areej El-Jawahri; Thomas LeBlanc; Harry VanDusen; Lara Traeger; Joseph A Greer; William F Pirl; Vicki A Jackson; Jason Telles; Alison Rhodes; Thomas R Spitzer; Steven McAfee; Yi-Bin A Chen; Stephanie S Lee; Jennifer S Temel Journal: JAMA Date: 2016-11-22 Impact factor: 56.272
Authors: Timothy S Sannes; Teresa L Simoneau; Susan K Mikulich-Gilbertson; Crystal L Natvig; Benjamin W Brewer; Kristin Kilbourn; Mark L Laudenslager Journal: Support Care Cancer Date: 2018-10-24 Impact factor: 3.603
Authors: Areej El-Jawahri; Thomas W LeBlanc; Linda J Burns; Ellen Denzen; Christa Meyer; Lih-Wen Mau; Eric J Roeland; William A Wood; Effie Petersdorf Journal: Cancer Date: 2018-10-05 Impact factor: 6.860
Authors: Areej R El-Jawahri; Harry B Vandusen; Lara N Traeger; Joel N Fishbein; Tanya Keenan; Emily R Gallagher; Joseph A Greer; William F Pirl; Vicki A Jackson; Thomas R Spitzer; Yi-Bin A Chen; Jennifer S Temel Journal: Cancer Date: 2015-12-09 Impact factor: 6.860